Article thumbnail

H. pylori Seropositivity before Age 40 and Subsequent Risk of Stomach Cancer: A Glimpse of the True Relationship?

By Christina Persson, Yanbin Jia, Helena Pettersson, Joakim Dillner, Olof Nyrén and Weimin Ye

Abstract

Stomach carcinogenesis involves mucosal and luminal changes that favor spontaneous disappearance of Helicobacter pylori. Therefore, the association between the infection and cancer risk might typically be underestimated. As acquisition of the infection almost invariably occurs before adulthood, the serostatus at age 16–40 should best reflect the lifetime occurrence of the infection. We therefore conducted a case-control study nested within a historic cohort of about 400,000 individuals who donated sera before age 40 to either of two large Swedish Biobanks between 1968 and 2006, and whose records were linked to complete nationwide registers. For each stomach adenocarcinoma case occurring at least 5 years after serum donation 2 controls were selected matched on age, sex and year of donation and biobank. Serum immunoglobulin G antibodies against H. pylori cell-surface antigens (Hp-CSAs) were measured with an enzyme–linked immunosorbent assay and antibodies against CagA with an immunoblot assay. Conditional logistic regression models were used to estimate odds ratios (ORs) for stomach adenocarcinoma among H. pylori infected relative to uninfected. We confirmed 59 incident cases of stomach adenocarcinoma (41 non-cardia tumors) during follow-up. ORs for non-cardia stomach adenocarcinoma among subjects with Hp-CSA antibodies (regardless of CagA serostatus), antibodies against CagA (regardless of Hp-CSA serostatus), and antibodies to both, relative to those who were seronegative to both, were 17.1 (95% confidence interval [CI] 4.0–72.9), 10.9 (95% CI 3.2–36.9), and 48.5 (95% CI 5.8–407.4), respectively. H. pylori infection is a much stronger risk factor for non-cardia stomach adenocarcinoma than initially realized. However, further studies are needed to answer whether it is a necessary cause, as the possibility of misclassification of H. pylori status could not be ruled out in our study

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3047545
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1984). A
  2. (1999). Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.
  3. (2001). Cancer Collaborative Group
  4. (2001). Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.
  5. (2003). Epidemiology of Helicobacter pylori infection.
  6. (2007). Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
  7. (2009). Epidemiology of stomach cancer.
  8. (2008). Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.
  9. (2006). Gastric cancer: global pattern of the disease and an overview of environmental risk factors.
  10. (1994). H pylori and gastric cancer.
  11. (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas.
  12. (2001). Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.
  13. (1995). Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.
  14. (2010). Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. H. pylori and Stomach Cancer: A True Relationship?
  15. (2001). Helicobacter pylori infection and the development of gastric cancer.
  16. (2007). Helicobacter pylori infection and the risk of gastric malignancy.
  17. (1996). IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting.
  18. (2010). Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies.
  19. (2004). Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?
  20. (2006). Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
  21. (1980). Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community.
  22. (2008). Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
  23. (1994). Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
  24. (1991). Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays.
  25. (2008). Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
  26. (2009). The completeness of the Swedish Cancer Register: a sample survey for year
  27. (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma an attempt at a histo-clinical classification.